Pharmaceutical Preparations · CIK 1420565
Developing novel therapies for orphan pulmonary and fibrosis indications with limited effective treatments
Comparable business profile · signals at a glance
In the 90 days to Nov 14, 2025: 2 insiders bought $551K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 14, 2025 | Voss Value Master Fund, LpTenPercentOwner | Buy | 104,183 | $1.22 | $127K |
| Oct 28, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 178,392 | $1.39 | $248K |
| Oct 27, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 92,642 | $1.37 | $127K |
| Oct 27, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 4,840 | $1.37 | $7K |
| Oct 24, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 30,176 | $1.39 | $42K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.